1 Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For May 05, 2025
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! May 24, 2025
Read More Apparatus J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Jun 02, 2025